Search

Earnings for the medical supplies industry have been good during the year 2002, especially the dental supply sector. The market for medical supplies, especially stents, is being transformed for the better, also. There are many good stocks for the investor to select in this industry.

The medical supplies industry has done well in early 2002 compared to other healthcare sectors. Earnings have improved and several companies have seen their stocks increase in value. These diverse stocks are worth consideration by investors.

Stocks in the medical supplies industry remain well-ranked in the year 2002 and this is expected to continue. Supplies for the treatment of cardiovascular artery disease, such as stents, are expected to help the industry's bottom line. Investors need to be selective with these stocks, however.

Demographics and good earnings have drawn investors to the medical supplies industry after the failures in the dot com and telecommunications industries. Valuations are high, however, due to the industry's strong performance. These stocks are timely for 2001 and 2002, but investors need to be selective.

The medical supplies industry is expected to outperform the stock market through the summer of 2002, due to good revenue performance. Earnings growth is expected to remain steady. These stocks are timely for 2001 and 2002, but investors need to be selective.

Stocks in the medical supplies industry have continued to do well in 2001, and this is expected to remain the case in the future. Consolidation has increased in 2001 after a quiet year for acquisitions in 2000. These stocks are timely for 2001 and for the next three to five years, as well.

The shares of Osteotech, Inc. have a wide price appreciation potential over the 2011-2013 timeframe. The Eatontown, New Jersey-based company engages in the processing of human bone and bone-connective tissue for use in transplants, and in the development of biomaterial and implant products for muscoloskeletal surgery.

The shares of Osteotech Inc. offer wide recovery potential over the 2011-2013 timeframe. The Eatontown, New Jersey-based company processes human bone and bone-connective tissue for use in transplants and develops biomaterial and implant products for musculoskeletal surgery.

The shares of Osteotech Inc. offer wide appreciation potential over the 2011-2013 timeframe. The Eatonview, New Jersey-based company processes human bone and bone-connective tissue for transplants and develops products for musculoskeletal surgery.

The shares of Osteotech Inc. have wide price appreciation potential over the 2010-2012 timeframe. The Estontown, New Jersey-based company processes human bone and bone-connective tissue for use in transplants and develops products for musculoskeletal surgery.

The article provides the price appreciation potential of the shares of Osteotech Inc. for the years 2010-2012. The company offers biomaterial and implant products for muscuskeletal surgery and processes human bone and bone-connective tissue for transplant use.

A comparative analysis of the sales earnings and the financial details of Osteotech, Inc. from the year 1994-2003 are detailed. Different financial ratios according to the Value Line Publication are given.